4
Changes in Ownership
TENAX THERAPEUTICS, INC. Filed Acc 0000919574-20-005666
Director bought 86,000 shares at an average $1.43 ($123,240)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC Director | 2020-09-01 | Purchase | +30,000 | $1.46 | $43,800 | 1,931,995 | D: show line 1 in the form |
| ARMISTICE CAPITAL, LLC Director | 2020-09-01 | Purchase | +0 | 1,931,995 | I: show line 2 in the form | ||
| ARMISTICE CAPITAL, LLC Director | 2020-09-02 | Purchase | +20,000 | $1.47 | $29,400 | 1,951,995 | D: show line 3 in the form |
| ARMISTICE CAPITAL, LLC Director | 2020-09-02 | Purchase | +0 | 1,951,995 | I: show line 4 in the form | ||
| ARMISTICE CAPITAL, LLC Director | 2020-09-03 | Purchase | +36,000 | $1.39 | $50,040 | 1,987,995 | D: show line 5 in the form |
| ARMISTICE CAPITAL, LLC Director | 2020-09-03 | Purchase | +0 | 1,987,995 | I: show line 6 in the form | ||
| Open-market purchases · 86,000 sh · avg $1.43 · $123,240 | |||||||
Loading xslF345X03/ownership.xml…